Using such approaches, researchers have detected the upregulated expression of various key glycolytic enzymes, such as hexokinase 2 (HK2), phosphoglycerate kinase 1 (PGK1), aldolase, and lactate dehydrogenase A (LDHA), in multiple tumor cell types (17–19). The gene discussed is HK2; the disease is neoplasm.